SAFE Task Force releases two position statements
Two papers aimed for NMO representatives use in their advocacy work on access to immunoglobulin replacement therapies
This author has yet to write their bio.Meanwhile lets just say that we are proud IPOPI contributed a whooping 172 entries.
Two papers aimed for NMO representatives use in their advocacy work on access to immunoglobulin replacement therapies
PIDs and Skin, PIDs and Cancer, Hyper IgE Syndrome, Ataxia-Telangiectasia, A Guide for Hepatologists and Genetic Diagnosis of PIDs
An interactive tool built on 6 key principles of care that measures the status of the PID healthcare environment across the globe
Global immunoglobulin supply: steaming towards the iceberg? A new article looking at plasma collection and immunoglobulin supply dynamics has just been published. In “Global immunoglobulin supply: steaming towards the iceberg?”, IPOPI’s Executive Director Johan Prevot and Professor Stephen Jolles (University Hospital of Wales) describe how plasma is sourced for fractionation into plasma-derived medicinal products (PDMPs), […]
Belgium
Avenue Louise/Louizalaan 65, Bte 11
BE-1050 Brussels, Belgium
IPOPI aisbl is an international non-profit association registered in Belgium
Numéro d’entreprise
BE 0761.784.055
Email: info@ipopi.org
Tel: +32 2 790 73 66 (Belgium)